UnitedHealth Group Incorporated $UNH is Pacific Capital Partners Ltd’s 9th Largest Position

Pacific Capital Partners Ltd increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 36.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 11,750 shares of the healthcare conglomerate’s stock after buying an additional 3,125 shares during the period. UnitedHealth Group accounts for about 4.1% of Pacific Capital Partners Ltd’s holdings, making the stock its 9th largest holding. Pacific Capital Partners Ltd’s holdings in UnitedHealth Group were worth $3,879,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC grew its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. CMT Capital Markets Trading GmbH purchased a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $340,000. Sepio Capital LP raised its holdings in UnitedHealth Group by 0.8% in the 2nd quarter. Sepio Capital LP now owns 5,734 shares of the healthcare conglomerate’s stock worth $1,789,000 after acquiring an additional 46 shares during the last quarter. Finally, Smith Moore & CO. boosted its stake in UnitedHealth Group by 6.6% during the 2nd quarter. Smith Moore & CO. now owns 2,368 shares of the healthcare conglomerate’s stock valued at $739,000 after purchasing an additional 146 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 1.1%

NYSE:UNH opened at $261.83 on Tuesday. The firm has a market capitalization of $237.66 billion, a price-to-earnings ratio of 19.85, a price-to-earnings-growth ratio of 1.19 and a beta of 0.41. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The business has a fifty day moving average price of $289.00 and a 200-day moving average price of $321.61. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $606.36.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion during the quarter, compared to analysts’ expectations of $113.38 billion. During the same quarter in the prior year, the business posted $6.81 earnings per share. The business’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s dividend payout ratio is presently 67.02%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on UNH. Truist Financial lowered their price target on UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. UBS Group lowered their target price on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Barclays decreased their price objective on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating for the company in a report on Friday, January 30th. Royal Bank Of Canada reduced their price objective on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating for the company in a research report on Wednesday, January 28th. Finally, Mizuho cut their price target on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research note on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.